By Zach Winnick ( June 12, 2012, 6:57 PM EDT) -- Eli Lilly & Co. plans to increase its investment in Chinese generic and specialty pharmaceutical manufacturer Novast Laboratories Ltd. by $20 million, the Indianapolis-based pharmaceutical giant announced Tuesday, saying the equity investment will help it build a portfolio of Lilly-branded generics in China....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.